- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
27 result(s) found for: Cannabinoid.
Displaying page 1 of 2.
EudraCT Number: 2015-004227-31 | Sponsor Protocol Number: 1312/BP | Start Date*: 2016-06-10 |
Sponsor Name:OA Dr. Philipp Becker c/o Abteilung für Wirbelsäulenchirurgie, Orthopädisches Spital Speising GmbH | ||
Full Title: Clinical pilot study to review the impact of perioperative administration of the synthetic cannabinoid nabilone in the context of spinal fusion surgery on the coping with surgery and the pain perce... | ||
Medical condition: Spine disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-005631-29 | Sponsor Protocol Number: 24420221 | Start Date*: 2008-06-18 | |||||||||||
Sponsor Name:Center for Spiseforstyrrelse, Endokrinologisk Afdeling M, Odense Universitetshospital | |||||||||||||
Full Title: Cannabinoid CB1 receptor agonist treatment in severe chronic anorexia nervosa | |||||||||||||
Medical condition: severe chronic Anorexia Nervosa | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004247-30 | Sponsor Protocol Number: THC-phMRI in patients | Start Date*: 2008-09-09 | ||||||||||||||||
Sponsor Name:University Medical Center Utrecht | ||||||||||||||||||
Full Title: The Role of the Endocannabinoid System in Psychiatric Disorders and Symptoms: a Pharmacological fMRI study | ||||||||||||||||||
Medical condition: THis research project will be performed with patients with a psychiatric disorder in order to determine whether the endocannabinoid system is altered in psychiatric diseases. Psychistric disorders ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: NL (Temporarily Halted) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004378-92 | Sponsor Protocol Number: EdomTHC | Start Date*: 2019-05-27 | |||||||||||
Sponsor Name:Fundació Clínic per la Recerca Biomèdica | |||||||||||||
Full Title: Effect of cannabinoids (THC / CBD) on hyperalgesia in patients with deep endometriosis | |||||||||||||
Medical condition: Deep endometriosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013647-10 | Sponsor Protocol Number: 2P50-DA012756-11 | Start Date*: 2009-12-10 |
Sponsor Name:National Institute on Drug Abuse (NIDA) | ||
Full Title: Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland | ||
Medical condition: Amphetamine dependence | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IS (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005553-39 | Sponsor Protocol Number: 1501 | Start Date*: 2015-12-29 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Effects of Sativex on blood leukocytes in patients with lymphoma/chronic lymphocytic leukaemia | ||
Medical condition: Lymphoma and chronic lymphocytic leukaemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001787-71 | Sponsor Protocol Number: CCB-CRC-07-01 | Start Date*: 2008-02-11 |
Sponsor Name:Charité - Universitätsmedizin Berlin | ||
Full Title: The influence of Rimonabant induced cannabinoid receptor blocking on the mass and function of the left ventricle in patients with abdominal adiposity | ||
Medical condition: Adiposity is another risk factor for developing cardiac insufficiency and myocardial hypertrophy. Probably the volume loading of the left ventricle, systemic inflammation, the fatty degeneration of... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-001404-37 | Sponsor Protocol Number: CARDIO-REDUSE | Start Date*: 2006-09-12 |
Sponsor Name:Maastricht University | ||
Full Title: Cardiometabolic risk reduction by Rimonabant: the effectiveness in daily practice and its use | ||
Medical condition: Despite therapeutic advances, cardio metabolic disease still remains an important cause of death worldwide. The endocannabinoid system seems to be a new target for multiple risk factor management a... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-005013-47 | Sponsor Protocol Number: FAAH2 | Start Date*: 2017-02-28 | |||||||||||
Sponsor Name:Linköping University | |||||||||||||
Full Title: Effects of the FAAH inhibitor PF-04457845 on fear extinction in healthy volunteers | |||||||||||||
Medical condition: Healthy volunteers (extinction of fear) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002691-18 | Sponsor Protocol Number: CBA106809 | Start Date*: 2006-10-03 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development | |||||||||||||
Full Title: A multi-centre, randomised, single-blind, placebo-controlled, parallel group study to investigate the efficacy of single pre-emptive doses of GW842166X, a non-cannabinoid CB2 receptor agonist, on p... | |||||||||||||
Medical condition: Inflammatory Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) IT (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002728-33 | Sponsor Protocol Number: CUPID2005 | Start Date*: 2006-02-28 |
Sponsor Name:Plymouth Hospitals NHS Trust | ||
Full Title: Cannabinoid Use in Progressive Inflammatory brain Disease | ||
Medical condition: Progressive multiple sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001834-27 | Sponsor Protocol Number: GWEP1415 | Start Date*: 2015-01-14 | |||||||||||
Sponsor Name:GW Research Ltd | |||||||||||||
Full Title: An open label extension study to investigate the safety of cannabidiol (GWP42003-P; CBD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes | |||||||||||||
Medical condition: Dravet Syndrome (DS) or Lennox-Gastaut Syndrome (LGS) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) PL (Completed) NL (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000212-22 | Sponsor Protocol Number: GWAP1241 | Start Date*: 2013-12-13 | |||||||||||
Sponsor Name:GW Research Ltd | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled, parallel group study of GWP42003 as adjunctive therapy in the first line treatment of schizophrenia or related psychotic disorder | |||||||||||||
Medical condition: Schizophrenia or related psychotic disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) PL (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000878-11 | Sponsor Protocol Number: OMO1.01.02 | Start Date*: 2017-06-08 | |||||||||||
Sponsor Name:OCTIMET Oncology NV | |||||||||||||
Full Title: A modular, multi-arm, multi-part, first time in patient study to evaluate the safety and tolerability of OMO-1, alone and in combination with anti-cancer treatments, in patients with locally advanc... | |||||||||||||
Medical condition: Locally advanced, unresectable or metastatic solid malignancies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) NL (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001056-17 | Sponsor Protocol Number: 3606 | Start Date*: 2020-08-14 | ||||||||||||||||
Sponsor Name:Kings's College London [...] | ||||||||||||||||||
Full Title: A randomised feasibility trial investigating Sativex® for the treatment of the Agitation & Aggression (A/A) in Alzheimer’s Dementia. | ||||||||||||||||||
Medical condition: Clinically significant agitation in Alzheimer's Diseases | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000907-13 | Sponsor Protocol Number: 2007-24-001 | Start Date*: 2007-11-13 | ||||||||||||||||||||||||||
Sponsor Name:MUW, Innere Med III, Abt.für Endokrinologie & Stoffwechsel | ||||||||||||||||||||||||||||
Full Title: The impact of Rimonabant in overweight women with prior gestational diabetes | ||||||||||||||||||||||||||||
Medical condition: Rimonabant has been shown to reduce body weight and improve cardiovascular risk factors and metabolic control. Therefore we investigate in women with previous gestational diabetes and impaired glu... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-001015-38 | Sponsor Protocol Number: SMRI-07TAF-1152 | Start Date*: 2008-09-19 | |||||||||||
Sponsor Name:LWL University Hospital Bochum, Ruhr-University Bochum | |||||||||||||
Full Title: A randomized, placebo-controlled study of the central cannabinoid (CB1) receptor antagonist rimonabant as adjunctive therapy to improve cognition in schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000271-39 | Sponsor Protocol Number: 2022-01 | Start Date*: 2022-09-02 | |||||||||||
Sponsor Name:Adeptio Pharmaceuticals Ltd | |||||||||||||
Full Title: Single-arm, open-label dose titration phase 2 clinical trial of (+)-α-DHTBZ for the treatment of tardive dyskinesia (TD) | |||||||||||||
Medical condition: Tardive dyskinesia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004823-66 | Sponsor Protocol Number: ELTCAN1 | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Early-life stress, the endocannabinoid system, and fear memory extinction | |||||||||||||
Medical condition: healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002940-42 | Sponsor Protocol Number: GWEP1414 | Start Date*: 2015-07-28 | |||||||||||
Sponsor Name:GW Research Ltd | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut synd... | |||||||||||||
Medical condition: Lennox-Gastaut syndrome (LGS) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.